Serum HSP70 level in patients with endometrial cancer with and without diabetes.

Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
Firouzeh HeidariManouchehr Nakhjavani

Abstract

Diabetes mellitus (DM) is associated with an increased risk of endometrial carcinoma (EC). Heat shock proteins have a role in the modulation of both diseases. The aim of this study was to investigate extracellular HSP70 (eHSP70) level alternations in patients with two different types of EC (endometrioid and non-endometrioid) with and without type 2 diabetes. In a case-control study, 88 participants were enrolled in four groups including: 18 EC patients with DM, 19 EC patients without DM, 29 patients with DM, and 22 healthy individuals. Blood samples were taken before surgery in cancer patients. Estradiol, eHSP70, sex hormone-binding globulin (SHBG), FBS, and HbA1c were assessed. Serum HSP70 level was higher in patients with diabetes (52.24 ± 14.2 ng/ml) compared to healthy controls (39.04 ± 6.96) (p < .05). It was lower in EC (26.05 ± 12.28) compared to healthy controls (39.04 ± 6.96) (p < .05). eHSP70 was also lower in endometrioid-type carcinoma (22.57 ± 11) compared to non-endometrioid type (31.55 ± 12.38) (p < .05). Further analysis showed increased levels of eHSP70 in patients having both endometrioid-type carcinoma and diabetes (27.23 ± 11.41) compared to the same patients without DM (17.08 ± 7.78) (p < .05). Presence of ...Continue Reading

References

Apr 1, 1986·Cancer·L Deligdisch, C F Holinka
Apr 7, 1993·Journal of the National Cancer Institute·D R CioccaW L McGuire
Jan 8, 1998·International Journal of Cancer. Journal International Du Cancer·X F SunB Nordenskjöld
Dec 25, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Makoto ChumaSetsuo Hirohashi
Dec 4, 2003·International Journal of Cancer. Journal International Du Cancer·Annekatrin LukanovaAnne Zeleniuch-Jacquotte
Mar 17, 2005·Cellular and Molecular Life Sciences : CMLS·M P Mayer, B Bukau
Jul 26, 2005·Cell Stress & Chaperones·Daniel R Ciocca, Stuart K Calderwood
Mar 2, 2006·International Journal of Clinical Oncology·Tanri Shiozawa, Ikuo Konishi
Oct 6, 2009·Leukemia Research·Chen-Hsiung YehMaher Albitar
Dec 17, 2009·Journal of Leukocyte Biology·Nina C DempseyJohn H H Williams
May 25, 2010·Cell Stress & Chaperones·Manouchehr NakhjavaniTiago F Outeiro
Dec 15, 2010·International Journal of Cancer. Journal International Du Cancer·Laure DossusRudolf Kaaks
Mar 19, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Tao WangGloria Y F Ho
Jan 16, 2013·International Journal of Cancer. Journal International Du Cancer·Perri RozenbergZvi Fishelson
Oct 28, 2014·Oncogene·M Y Sherman, V L Gabai
Jan 6, 2015·BMJ : British Medical Journal·Konstantinos K TsilidisJohn P A Ioannidis
Jan 9, 2016·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Feb 13, 2016·Cell Stress & Chaperones·Jürgen Radons
Feb 15, 2016·Trends in Biochemical Sciences·Stuart K Calderwood, Jianlin Gong
Nov 3, 2016·Nature Reviews. Clinical Oncology·Adi J Klil-DroriMichael N Pollak

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Related Papers

The New England Journal of Medicine
Robert SempleSteven O'Rahilly
The New England Journal of Medicine
Norbert StefanHans-Ulrich Häring
Nihon rinsho. Japanese journal of clinical medicine
H Saito, S Yoshida
Nihon rinsho. Japanese journal of clinical medicine
H Suzuki, H Ito
© 2021 Meta ULC. All rights reserved